Use of interferon in cytomegalovirus infections in man
- PMID: 211670
Use of interferon in cytomegalovirus infections in man
Abstract
Human CMV is relatively sensitive to the antiviral effects of interferon in vitro. No controlled studies of interferon in human CMV infections have been reported. On the basis of case reports published to date, its usefulness in CMV infections of newborns or transplant recipients is unclear. Double-blind, placebo-controlled studies of interferon prophylaxis against CMV infections in renal transplant recipients are currently underway.
Similar articles
-
Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.Bone Marrow Transplant. 1996 Apr;17(4):589-93. Bone Marrow Transplant. 1996. PMID: 8722360 Clinical Trial.
-
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.N Engl J Med. 1979 Jun 14;300(24):1345-9. doi: 10.1056/NEJM197906143002401. N Engl J Med. 1979. PMID: 220536 Clinical Trial.
-
Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.Transpl Infect Dis. 2005 Jun;7(2):71-4. doi: 10.1111/j.1399-3062.2005.00089.x. Transpl Infect Dis. 2005. PMID: 16150094
-
Prevention of cytomegalovirus disease in renal allograft recipients.Scand J Infect Dis Suppl. 1991;80:88-93. Scand J Infect Dis Suppl. 1991. PMID: 1725064 Review.
-
Immunoprophylaxis against cytomegalovirus disease.Scand J Infect Dis Suppl. 1995;99:105-9. Scand J Infect Dis Suppl. 1995. PMID: 8668931 Review.
Cited by
-
Inactivators of fibroblast interferon found in human serum.Infect Immun. 1979 Jun;24(3):851-5. doi: 10.1128/iai.24.3.851-855.1979. Infect Immun. 1979. PMID: 89091 Free PMC article.